Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 534

1.

ShadowR: a novel chromoprotein with reduced non-specific binding and improved expression in living cells.

Murakoshi H, Horiuchi H, Kosugi T, Onda M, Sato A, Koga N, Nabekura J.

Sci Rep. 2019 Aug 19;9(1):12072. doi: 10.1038/s41598-019-48604-4.

2.

Multimodal Imaging in Bilateral Nature of the Choroidal Osteoma After Intraocular Inflammation Caused by Harada Disease.

Ozawa K, Iwase T, Ito Y, Onda M, Shiraki I, Kumada M, Ito R, Mochizuki K.

Retina. 2019 Sep;39(9):e40-e41. doi: 10.1097/IAE.0000000000002611. No abstract available.

PMID:
31306294
3.

The change in pharmacists' attitude, confidence and job satisfaction following participation in a novel hypertension support service.

Shoji M, Onda M, Okada H, Sakane N, Nakayama T.

Int J Pharm Pract. 2019 Dec;27(6):520-527. doi: 10.1111/ijpp.12550. Epub 2019 Jun 10.

PMID:
31179618
4.

Depletion of regulatory T cells in tumors with an anti-CD25 immunotoxin induces CD8 T cell-mediated systemic antitumor immunity.

Onda M, Kobayashi K, Pastan I.

Proc Natl Acad Sci U S A. 2019 Mar 5;116(10):4575-4582. doi: 10.1073/pnas.1820388116. Epub 2019 Feb 13.

5.

Human Herpesvirus-6 corneal Endotheliitis after intravitreal injection of Ranibizumab.

Onda M, Niimi Y, Ozawa K, Shiraki I, Mochizuki K, Yamamoto T, Sugita S, Ishida K.

BMC Ophthalmol. 2019 Jan 16;19(1):19. doi: 10.1186/s12886-019-1032-2.

6.

Elevated Serum Megakaryocyte Potentiating Factor as a Predictor of Poor Survival in Patients with Mesothelioma and Primary Lung Cancer.

Yu Y, Ryan BM, Thomas A, Morrow B, Zhang J, Kang Z, Zingone A, Onda M, Hassan R, Pastan I, Cao L.

J Appl Lab Med. 2018 Sep;3(2):166-177. doi: 10.1373/jalm.2017.025015.

7.

Megakaryocyte Potentiating Factor as a Predictive Biomarker for Therapies Against Malignant Mesothelioma.

Cao L, Yu Y, Thomas A, Zhang J, Onda M, Meltzer P, Hassan R, Pastan I.

JCO Precis Oncol. 2018;2018. doi: 10.1200/PO.17.00282. Epub 2018 May 11.

8.

[Outcomes of Pharmacists' Involvement with Residents of Special Nursing Homes for the Elderly].

Hashimoto R, Fujii K, Yoshida K, Shimoji S, Masaki H, Kadoyama K, Nakamura T, Onda M.

Yakugaku Zasshi. 2018;138(9):1217-1225. doi: 10.1248/yakushi.18-00065. Japanese.

9.

Heat-Induced Aggregation of Hen Ovalbumin Suggests a Key Factor Responsible for Serpin Polymerization.

Noji M, So M, Yamaguchi K, Hojo H, Onda M, Akazawa-Ogawa Y, Hagihara Y, Goto Y.

Biochemistry. 2018 Sep 18;57(37):5415-5426. doi: 10.1021/acs.biochem.8b00619. Epub 2018 Sep 6.

PMID:
30148614
10.

Crystalloid Granuloma of Parotid Gland: A Case Report With Review of the Literature.

Motoda N, Onda M, Nakamizo M, Ohashi R, Okubo K, Naito Z.

Int J Surg Pathol. 2019 Apr;27(2):216-220. doi: 10.1177/1066896918791031. Epub 2018 Jul 27. Review.

PMID:
30051740
11.

[Factors Related to the Awareness and Self-confidence of Pharmacists regarding "PRE-AVOID": Study Using VISTA Project Data].

Maeta N, Shoji M, Hashimoto M, Arakawa Y, Onda M.

Yakugaku Zasshi. 2018;138(5):723-729. doi: 10.1248/yakushi.17-00222. Japanese.

12.

[Viral and Electrophysiological Approaches for Elucidating the Structure and Function of Retinal Circuits].

Onda M, Sansawa K, Osakada F.

Yakugaku Zasshi. 2018;138(5):669-678. doi: 10.1248/yakushi.17-00200-1. Review. Japanese.

13.
14.

Recombinant immunotoxins with albumin-binding domains have long half-lives and high antitumor activity.

Wei J, Bera TK, Liu XF, Zhou Q, Onda M, Ho M, Tai CH, Pastan I.

Proc Natl Acad Sci U S A. 2018 Apr 10;115(15):E3501-E3508. doi: 10.1073/pnas.1721780115. Epub 2018 Mar 26.

15.

Potential Interference of Oil Vehicles on Genital Tubercle Development during the Fetal Period in ICR Mice.

Nishioka Y, Tamai K, Onda M, Hiromori Y, Kimura T, Hu J, Nagase H, Nakanishi T.

Biol Pharm Bull. 2018;41(2):266-271. doi: 10.1248/bpb.b17-00830.

16.

Tolerogenic nanoparticles restore the antitumor activity of recombinant immunotoxins by mitigating immunogenicity.

Mazor R, King EM, Onda M, Cuburu N, Addissie S, Crown D, Liu XF, Kishimoto TK, Pastan I.

Proc Natl Acad Sci U S A. 2018 Jan 23;115(4):E733-E742. doi: 10.1073/pnas.1717063115. Epub 2018 Jan 8. Review.

17.

Effects of lifestyle advice provided by pharmacists on blood pressure: The COMmunity Pharmacists ASSist for Blood Pressure (COMPASS-BP) randomized trial.

Okada H, Onda M, Shoji M, Sakane N, Nakagawa Y, Sozu T, Kitajima Y, Tsuyuki RT, Nakayama T.

Biosci Trends. 2018 Jan 9;11(6):632-639. doi: 10.5582/bst.2017.01256. Epub 2017 Dec 18.

18.

Fish protein hydrolysate exhibits anti-obesity activity and reduces hypothalamic neuropeptide Y and agouti-related protein mRNA expressions in rats.

Mizushige T, Komiya M, Onda M, Uchida K, Hayamizu K, Kabuyama Y.

Biomed Res. 2017;38(6):351-357. doi: 10.2220/biomedres.38.351.

19.

Toward understanding structure and function of neural circuits in the visual system.

Onda M, Osakada F.

Nihon Yakurigaku Zasshi. 2017;149(6):274-280. doi: 10.1254/fpj.149.274. Japanese. No abstract available.

PMID:
28626120
20.

Imaging findings of solitary uterine granulocytic sarcoma.

Yamane A, Sekine T, Machida T, Omori I, Onda M, Kumita SI.

Acta Radiol Open. 2017 Mar 28;6(3):2058460117701515. doi: 10.1177/2058460117701515. eCollection 2017 Mar.

21.

Comprehensive immunohistochemical study of mesothelin (MSLN) using different monoclonal antibodies 5B2 and MN-1 in 1562 tumors with evaluation of its prognostic value in malignant pleural mesothelioma.

Inaguma S, Wang Z, Lasota J, Onda M, Czapiewski P, Langfort R, Rys J, Szpor J, Waloszczyk P, OkoĊ„ K, Biernat W, Ikeda H, Schrump DS, Hassan R, Pastan I, Miettinen M.

Oncotarget. 2017 Apr 18;8(16):26744-26754. doi: 10.18632/oncotarget.15814.

22.

How Patient-Pharmacist Communication Using the Drug Profile Book Relates to Patient's Behavior regarding Its Use.

Shoji M, Iwade K, Fujii K, Hirota M, Kanou A, Moriya M, Ishii M, Shimoji S, Onda M, Arakawa Y.

Yakugaku Zasshi. 2016;136(10):1427-1431.

23.

Characterization of a re-engineered, mesothelin-targeted Pseudomonas exotoxin fusion protein for lung cancer therapy.

Bauss F, Lechmann M, Krippendorff BF, Staack R, Herting F, Festag M, Imhof-Jung S, Hesse F, Pompiati M, Kollmorgen G, da Silva Mateus Seidl R, Bossenmaier B, Lau W, Schantz C, Stracke JO, Brinkmann U, Onda M, Pastan I, Bosslet K, Niederfellner G.

Mol Oncol. 2016 Oct;10(8):1317-29. doi: 10.1016/j.molonc.2016.07.003. Epub 2016 Jul 14.

24.

Protection of the Furin Cleavage Site in Low-Toxicity Immunotoxins Based on Pseudomonas Exotoxin A.

Kaplan G, Lee F, Onda M, Kolyvas E, Bhardwaj G, Baker D, Pastan I.

Toxins (Basel). 2016 Jul 25;8(8). pii: E217. doi: 10.3390/toxins8080217.

25.

Dual B- and T-cell de-immunization of recombinant immunotoxin targeting mesothelin with high cytotoxic activity.

Mazor R, Onda M, Park D, Addissie S, Xiang L, Zhang J, Hassan R, Pastan I.

Oncotarget. 2016 May 24;7(21):29916-26. doi: 10.18632/oncotarget.9171.

26.

Digestion of chrysanthemum stunt viroid by leaf extracts of Capsicum chinense indicates strong RNA-digesting activity.

Iraklis B, Kanda H, Nabeshima T, Onda M, Ota N, Koeda S, Hosokawa M.

Plant Cell Rep. 2016 Aug;35(8):1617-28. doi: 10.1007/s00299-016-1977-z. Epub 2016 Apr 6.

PMID:
27053224
27.

Immunogenicity of therapeutic recombinant immunotoxins.

Mazor R, Onda M, Pastan I.

Immunol Rev. 2016 Mar;270(1):152-64. doi: 10.1111/imr.12390. Review.

28.

Effectiveness of Pharmacists' Comprehensive Assessment of Medication Profiles in Dementia Patients.

Nanaumi Y, Onda M, Tsubota K, Tanaka R, Mukai Y, Matoba S, Tanaka Y, Arakawa Y.

Yakugaku Zasshi. 2015;135(9):1057-67. doi: 10.1248/yakushi.15-00109.

29.
30.

[Nationwide study on relations between workload and outcomes of home visiting service by community pharmacists].

Onda M, Imai H, Nanaumi Y, Hirano A, Fujii S, Arakawa Y.

Yakugaku Zasshi. 2015;135(3):519-27. doi: 10.1248/yakushi.14-00220. Japanese.

31.

Bortezomib reduces pre-existing antibodies to recombinant immunotoxins in mice.

Manning ML, Mason-Osann E, Onda M, Pastan I.

J Immunol. 2015 Feb 15;194(4):1695-701. doi: 10.4049/jimmunol.1402324. Epub 2015 Jan 5.

32.

An improved recombinant Fab-immunotoxin targeting CD22 expressing malignancies.

Bera TK, Onda M, Kreitman RJ, Pastan I.

Leuk Res. 2014 Oct;38(10):1224-9. doi: 10.1016/j.leukres.2014.06.014. Epub 2014 Jul 5.

33.

Tofacitinib suppresses antibody responses to protein therapeutics in murine hosts.

Onda M, Ghoreschi K, Steward-Tharp S, Thomas C, O'Shea JJ, Pastan IH, FitzGerald DJ.

J Immunol. 2014 Jul 1;193(1):48-55. doi: 10.4049/jimmunol.1400063. Epub 2014 Jun 2.

34.

Recombinant immunotoxin for cancer treatment with low immunogenicity by identification and silencing of human T-cell epitopes.

Mazor R, Eberle JA, Hu X, Vassall AN, Onda M, Beers R, Lee EC, Kreitman RJ, Lee B, Baker D, King C, Hassan R, Benhar I, Pastan I.

Proc Natl Acad Sci U S A. 2014 Jun 10;111(23):8571-6. doi: 10.1073/pnas.1405153111. Epub 2014 May 5.

35.

Spermatic cord tumor metastatic from stomach cancer 1 year after curative gastrectomy.

Kanazawa Y, Kato S, Fujita I, Onodera H, Takata H, Onda M, Naito Z, Uchida E.

J Nippon Med Sch. 2013;80(4):318-23.

36.

Pantothenic acid refeeding diminishes the liver, perinephrical fats, and plasma fats accumulated by pantothenic acid deficiency and/or ethanol consumption.

Shibata K, Fukuwatari T, Higashiyama S, Sugita C, Azumano I, Onda M.

Nutrition. 2013 May;29(5):796-801. doi: 10.1016/j.nut.2013.01.002. Epub 2013 Mar 17.

PMID:
23510569
37.

A recombinant immunotoxin against the tumor-associated antigen mesothelin reengineered for high activity, low off-target toxicity, and reduced antigenicity.

Weldon JE, Xiang L, Zhang J, Beers R, Walker DA, Onda M, Hassan R, Pastan I.

Mol Cancer Ther. 2013 Jan;12(1):48-57. doi: 10.1158/1535-7163.MCT-12-0336. Epub 2012 Nov 6.

38.

Recombinant immunotoxins with low endotoxins for clinical and animal studies.

Onda M.

Methods Mol Biol. 2012;907:627-43. doi: 10.1007/978-1-61779-974-7_35.

PMID:
22907377
39.

Recombinant immunotoxin engineered for low immunogenicity and antigenicity by identifying and silencing human B-cell epitopes.

Liu W, Onda M, Lee B, Kreitman RJ, Hassan R, Xiang L, Pastan I.

Proc Natl Acad Sci U S A. 2012 Jul 17;109(29):11782-7. doi: 10.1073/pnas.1209292109. Epub 2012 Jul 2.

40.

[The efficacy of the "BURP" maneuver during laryngoscopy and training period necessary for residents in anesthesiology].

Onda M, Inomata S, Satsumae T, Tanaka M.

Masui. 2012 Apr;61(4):444-7. Japanese.

PMID:
22590954
41.

Comparison of epirubicin-iodized oil suspension and emulsion for transcatheter arterial chemoembolization in VX2 tumor.

Ueda T, Murata S, Mine T, Onozawa S, Onda M, Naito Z, Amano Y, Kumita S.

ScientificWorldJournal. 2012;2012:961986. doi: 10.1100/2012/961986. Epub 2012 Mar 12.

43.

Comparative study of cisplatin-iodized oil suspension and emulsion for transcatheter arterial chemoembolization of rabbit VX2 liver tumors.

Mine T, Murata S, Ueda T, Onozawa S, Onda M, Naito Z, Kumita S.

Hepatol Res. 2012 May;42(5):473-81. doi: 10.1111/j.1872-034X.2011.00942.x. Epub 2011 Dec 16.

PMID:
22176437
44.

Serum mesothelin and megakaryocyte potentiating factor in pancreatic and biliary cancers.

Sharon E, Zhang J, Hollevoet K, Steinberg SM, Pastan I, Onda M, Gaedcke J, Ghadimi BM, Ried T, Hassan R.

Clin Chem Lab Med. 2012 Apr;50(4):721-5. doi: 10.1515/CCLM.2011.816.

45.

Effects of pantothenic acid supplement on secretion of steroids by the adrenal cortex in female rats.

Pan L, Jaroenporn S, Yamamoto T, Nagaoka K, Azumano I, Onda M, Watanabe G, Taya K.

Reprod Med Biol. 2011 Dec 2;11(2):101-104. doi: 10.1007/s12522-011-0113-6. eCollection 2012 Apr.

46.

A recombinant immunotoxin engineered for increased stability by adding a disulfide bond has decreased immunogenicity.

Liu W, Onda M, Kim C, Xiang L, Weldon JE, Lee B, Pastan I.

Protein Eng Des Sel. 2012 Jan;25(1):1-6. doi: 10.1093/protein/gzr053. Epub 2011 Nov 17.

47.

The improvement of an anti-CD22 immunotoxin: conversion to single-chain and disulfide stabilized form and affinity maturation by alanine scan.

Kawa S, Onda M, Ho M, Kreitman RJ, Bera TK, Pastan I.

MAbs. 2011 Sep-Oct;3(5):479-86. doi: 10.4161/mabs.3.5.17228. Epub 2011 Sep 1.

48.

Immuno-cell therapy with antecedent surgery has superior actuarial survival to immuno-cell therapy without antecedent surgery for advanced cancers.

Shindo G, Endo T, Onda M, Miyamoto Y, Kaneko T, Goto S.

Cancer Immunol Immunother. 2011 Oct;60(10):1397-403. doi: 10.1007/s00262-011-1044-0. Epub 2011 Jun 3.

PMID:
21638124
49.

[Research survey on the information gathering methods, attitudes, and requests from care managers about the pharmaceutical service by pharmacists in home care].

Nanaumi Y, Onda M, Sakurai H, Tanaka R, Tsubota K, Matoba S, Mukai Y, Arakawa Y, Hayase Y.

Yakugaku Zasshi. 2011;131(5):843-51. Japanese.

50.

Pentostatin plus cyclophosphamide safely and effectively prevents immunotoxin immunogenicity in murine hosts.

Mossoba ME, Onda M, Taylor J, Massey PR, Treadwell S, Sharon E, Hassan R, Pastan I, Fowler DH.

Clin Cancer Res. 2011 Jun 1;17(11):3697-705. doi: 10.1158/1078-0432.CCR-11-0493. Epub 2011 Apr 26.

Supplemental Content

Support Center